Skip to content
Fowler Lab
Fowler Lab

Predicting antibiotic resistance de novo

  • News
  • Publications
  • Members
  • Research
    • Overview
    • Manifesto
    • Software
    • Reproducibility
  • Teaching
  • Contact
    • PhDs
  • Wiki
Fowler Lab
Fowler Lab

Predicting antibiotic resistance de novo

Updated preprint: A validated cloud-based genomic platform for co-ordinated, expedient global analysis of SARS-CoV-2 genomic epidemiology

Philip Fowler, 23rd January 202528th January 2025

In August 2022 seven laboratories across the world uploaded their SARS-CoV-2 genetics files for processing to an online cloud processing platform. Since then the pipeline that is run (the Tiled Amplicon Pipeline) has been updated and deployed in a new, more flexible cloud-based platform, EIT Pathogena. Hence Junko Takada, with lots of help from others in the MMM Unit and elsewhere, re-wrote the original preprint to reflect these changes. You can read the new version here.

Share this:

  • Share on X (Opens in new window) X
  • Share on Bluesky (Opens in new window) Bluesky
  • Email a link to a friend (Opens in new window) Email
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on Mastodon (Opens in new window) Mastodon

Related

clinical microbiology gpas

Post navigation

Previous post
Next post

Related Posts

New publication: fast human read decontamination for SARS-CoV-2

16th May 202216th May 2022

ReadItAndKeep is a new human-read decontamination algorithm that works by mapping the reads in a…

Share this:

  • Share on X (Opens in new window) X
  • Share on Bluesky (Opens in new window) Bluesky
  • Email a link to a friend (Opens in new window) Email
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on Mastodon (Opens in new window) Mastodon
Read More

New preprint: automatically building a better bedaquiline catalogue

31st January 202531st January 2025

A catalogue recording whether individual mutations confer resistance or not to specified antibiotics is a…

Share this:

  • Share on X (Opens in new window) X
  • Share on Bluesky (Opens in new window) Bluesky
  • Email a link to a friend (Opens in new window) Email
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on Mastodon (Opens in new window) Mastodon
Read More

New preprint: Including minor alleles improves fluoroquinolone resistance prediction

10th November 202217th November 2022

Fluoroquinolones are used to treat both normal and drug resistant tuberculosis and therefore being able…

Share this:

  • Share on X (Opens in new window) X
  • Share on Bluesky (Opens in new window) Bluesky
  • Email a link to a friend (Opens in new window) Email
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on Mastodon (Opens in new window) Mastodon
Read More

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.

To find out more, including how to control cookies, see here: Cookie Policy
    ©2026 Fowler Lab | WordPress Theme by SuperbThemes